10-K: Performant Healthcare Reports Fiscal Year 2024 Results, Revenue Up 8%

Sentiment:

Annual Results


Performant Healthcare, Inc. announces its financial results for the year ended December 31, 2024, highlighting an 8% increase in revenue to $123.0 million.

Worse than expectedThe company's net loss increased from $7.5 million in 2023 to $9.9 million in 2024.

Summary

  • Performant Healthcare reported total revenues of $123.0 million for the year ended December 31, 2024, an 8% increase compared to $113.7 million in 2023.
  • Healthcare revenues increased by 11% to $118.3 million, driven by growth in commercial statements of work, the CMS Region 2 contract, and an increase in the scope of services for several commercial statements of work.
  • The company experienced a net loss of $9.9 million for the year ended December 31, 2024, compared to a net loss of $7.5 million in the previous year.
  • Adjusted EBITDA was $4.4 million, and adjusted net loss was $4.5 million for the year ended December 31, 2024.
  • The company's revenue per employee increased to approximately $125,000 in 2024 from $117,000 in 2023.
  • As of December 31, 2024, the company had $9.3 million in cash and cash equivalents, compared to $7.3 million as of December 31, 2023.
  • The company has a $25 million revolving loan commitment with Wells Fargo Bank, with $8.0 million outstanding as of December 31, 2024.

Sentiment

Score: 6

Explanation: The report shows revenue growth but also increased net losses, indicating a mixed financial performance. The company is expanding its services and securing new contracts, but profitability remains a concern.

Positives

  • Healthcare revenues increased by 11% due to growth in commercial and government contracts.
  • Claims-based service revenues saw a significant increase of 25%.
  • The company was awarded the New York State Recovery Audit Contractor contract.
  • Revenue per employee increased from $117,000 to $125,000.
  • The company secured a new credit agreement with Wells Fargo Bank in October 2023.

Negatives

  • The company reported a net loss of $9.9 million for 2024, an increase from the $7.5 million loss in 2023.
  • Customer Care / Outsourced Services revenues decreased by 35% due to a shift in business strategy.
  • Loss from operations increased by $3.4 million to $9.5 million for the year ended December 31, 2024.

Risks

  • The company faces significant competition in obtaining and retaining client contracts.
  • The company's ability to derive revenues under healthcare contracts depends on the number and types of potentially improper claims that clients allow them to audit.
  • Downturns in domestic or global economic conditions could harm the company's business and results of operations.
  • Public health emergencies such as the COVID-19 pandemic have adversely affected and could adversely affect the company's business, results of operations and financial condition.
  • The company is subject to extensive regulations regarding the use and disclosure of confidential personal information and failure to comply with these regulations could cause the company to incur liabilities and expenses.

Future Outlook

The company expects the need for its offerings to increase in the public and private healthcare markets, with a multi-pronged growth strategy for national, mid-tier, and smaller health plans.

Industry Context

The report notes that U.S. healthcare spending grew by 7.5% to $4.9 trillion in 2023, accounting for 17.6% of the nation's GDP, and is projected to grow at an average annual rate of 5.6% from 2023 to 2032.

Comparison to Industry Standards

  • The company competes with other healthcare payment integrity providers such as Cotiviti, Inc. and HMS Holdings, a subsidiary of Gainwell Technologies LLC.
  • Many of Performant's competitors in the government and healthcare sectors of the healthcare payment integrity market have greater resources than Performant does.

Legal Proceedings

  • The company is involved in various legal proceedings that arise from its normal business operations from time to time.

Stakeholder Impact

  • The company's performance impacts shareholders through stock value and potential returns.
  • Employees are affected by the company's ability to maintain and grow its operations.
  • Customers (healthcare payers) benefit from the company's services in identifying and recovering improper payments.

Next Steps

  • The company plans to seek a new Region 5 contract in 2025.
  • The company anticipates its services under the New York State Recovery Audit Contractor contract to commence in 2025.

Key Dates

DateDescription
2003Performant Healthcare, Inc. was formed.
2006The Tax Relief and Health Care Act of 2006 mandated CMS to contract with private firms to audit Medicare claims.
2008Performant was initially awarded a RAC contract with CMS.
2012Initial public offering in August 2012.
2016Performant was awarded two new RAC contracts with CMS for Regions 1 and 5.
2017CMS awarded the national exclusive MSP contract to Performant.
March 2021Performant was re-awarded the CMS Region 1 contract.
November 2022Performant was awarded the RAC contract to audit improper payments for claims made under Medicare Parts A and B in Region 2.
December 2022Performant was re-awarded the national exclusive MSP contract by CMS.
March 2023Performant commenced operations under the re-awarded MSP contract.
October 27, 2023Performant entered into a new credit agreement with Wells Fargo Bank.
2025Anticipated commencement of services under the New York State Recovery Audit Contractor contract.
December 31, 2024End of the fiscal year for which results are reported.
March 12, 202578,308,640 shares of the registrant's common stock were outstanding.
March 13, 2025Date of the filing of the 10-K report.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.